awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42174990-05848D32-3678-4931-92BF-D40A5BC8ABE6
Q42174990-05848D32-3678-4931-92BF-D40A5BC8ABE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42174990-05848D32-3678-4931-92BF-D40A5BC8ABE6
A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer
P2860
Q42174990-05848D32-3678-4931-92BF-D40A5BC8ABE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42174990-05848D32-3678-4931-92BF-D40A5BC8ABE6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9941c7226f5ee4b6232ce5162a62c91b5a99141a
P2860
Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.